<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
DYN
Dyne Therapeutics
$
()


  • Dyne Therapeutics CEO Joshua Brumm to step down, John Cox to succeed

    3/25/2024 - 07:47am
  • Dyne Therapeutics price target raised by $11 at Chardan, here's why

    3/8/2024 - 04:24am
  • Dyne Therapeutics price target raised by $4 at Guggenheim, here's why

    3/6/2024 - 11:33am
  • Dyne Therapeutics price target raised by $2 at Piper Sandler, here's why

    3/6/2024 - 07:21am
  • Dyne Therapeutics price target raised by $6 at Stifel, here's why

    3/6/2024 - 07:19am
  • Dyne Therapeutics files automatic mixed securities shelf

    3/5/2024 - 08:25am
  • Dyne Therapeutics price target raised by $3 at Oppenheimer, here's why

    3/5/2024 - 07:42am
  • Dyne Therapeutics reports Q4 EPS ($1.09), consensus (92c)

    3/5/2024 - 07:42am
  • Dyne Therapeutics initiated with bullish view at H.C. Wainwright, here's why

    2/20/2024 - 06:07am
  • What You Missed On Wall Street On Friday

    1/26/2024 - 16:33pm
  • Dyne Therapeutics resumes trading, up 29% after report of takeover interest

    1/26/2024 - 14:58pm
  • Dyne Therapeutics trading resumes

    1/26/2024 - 14:53pm
  • Dyne Therapeutics seeing takeover interest, weighing options, Bloomberg says

    1/26/2024 - 14:49pm
  • Dyne Therapeutics jumps as Bloomberg says company seeing takeover interest

    1/26/2024 - 14:32pm
  • Dyne Therapeutics seeing takeover interest, weighing options, Bloomberg says

    1/26/2024 - 14:29pm
dynamic_feed Breaking News